Fig. S1 The 3′UTR of Nampt mRNA contains a miR-34a binding site.

Fig. S2 Effects of high fat diet on hepatic NAMPT expression.

Fig. S3 Effects of miR-34a on NAMPT expression.

Fig. S4 Effects of in vivo silencing of miR-34a on NAMPT mRNA levels.

Fig. S5 Effects of downregulation of SIRT1 by siRNA on acetylation of NF-kB.

Fig. S6 Effects of Ad-miR-34a on expression of FA transport genes.

Fig. S7 Effects of Ad-miR-34a on glucose tolerance.

Fig. S8 Effects of Ad-miR-34a on liver staining by H&E.

Fig. S9 Effects of treatment with NMN on NAD+ levels.

Fig. 10 Effects of treatment with FK866 on cellular NAD+ levels.

Fig. S11 Effects of treatment with resveratrol on NAMPT protein and NAD+ levels.

Fig. S12 Effects of anti-miR-34a treatment on liver fat accumulation and macrophage infiltration.

Fig. S13 Effects of anti-miR-34a treatment on serum AST/ALT levels.

Fig. S14 Primer sequences for q-RTPCR analysis are shown.

Fig. S15 Primer sequences for semi-quantitative PCR for the ChIP assays are shown.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.